Contraceptive Technology Update – July 1, 2019
July 1, 2019
View Issues
-
LARC Contraceptives: Remove the Barriers
Despite guidance stating that a patient should be offered the option to begin her chosen long-acting reversible contraception birth control method at the time of the office visit rather than waiting for her next period or returning for another appointment, just 29% of clinicians say they provide same-day placement.
-
Researchers Investigate Contraceptive Vaginal Ring
Scientists are now investigating a nonhormonal monthly ring (Ovaprene) as a potential contraceptive. The device involves a permeable mesh in the center of the ring that creates a partial barrier to sperm and locally acting spermiostatic agents to create an inhospitable environment for sperm.
-
Antiretroviral Treatment Prevents Sexual Transmission of HIV in MSM
New research indicates that antiretroviral treatment that leads to viral suppression prevents sexual transmission of HIV in discordant gay male couples as well as it does among heterosexual couples.
-
Overcome Barriers to HPV Vaccination
A new analysis of a national survey underscores the importance of continued efforts to strengthen practitioner adoption of evidence-based approaches to recommending the HPV vaccine.
-
Science Focuses on the Use of Metronidazole for Endometriosis
Researchers are exploring the use of metronidazole for the treatment of endometriosis, which affects up to 10% of U.S. women between the ages of 25 and 40. The current treatment options include hormone therapy and surgery, but these approaches involve significant side effects and recurrence of the condition after treatment.
-
Legislators, Listen Up, Learn, and Perhaps Beware
Combined oral contraceptives have been shown to provide health benefits beyond birth control.
-
Time to Close Gaps in HIV Testing, Treatment
About 80% of new HIV transmissions can be linked to people whose infection is undiagnosed or is not currently treated, according to findings from a just-published analysis.
-
Drug Combination Considered for Treatment-Resistant Gonorrhea
Newly released research indicates that a certain combination of drugs, gentamicin and azithromycin, may work as well as ceftriaxone alone for cases of drug-resistant gonorrhea.
-
Annual User Survey